Navigation Links
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine
Date:10/16/2009

PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).

"The approval of CERVARIX will bring an important new cervical cancer vaccine to girls and young women," said Deirdre Connelly, President, North American Pharmaceuticals, GlaxoSmithKline. "Immunization with a vaccine such as CERVARIX -- along with annual doctor visits and Pap tests -- will help protect women from cervical cancer, the second leading cause of cancer death in women in their twenties and thirties."

CERVARIX was shown to be 93 percent efficacious in the prevention of cervical pre-cancers (cervical intraepithelial neoplasia 2+/ CIN 2+ or adenocarcinoma in situ) associated with HPV 16 or 18, in women without evidence of current infection with, or prior exposure to, the same HPV type at the time of vaccination. The majority (approximately 75 percent) of cervical cancers in North America are caused by HPV types 16 and 18.

The impact of CERVARIX against the overall burden of HPV-related cervical disease results from a combination of efficacy against, and disease contribution of, HPV-16, HPV-18, and oncogenic HPV types not included in the vaccine. In a subgroup of clinical trial participants without oncogenic HPV infection at the time of the first vaccination and without evidence of prior exposure to HPV 16 and 18, the vaccine showed an overall efficacy of 70 percent against pre-cancerous lesions, regardless of HPV type. In an additional analysis that assessed the impact of CERVARIX against spe
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  CAS Medical Systems, Inc. (NASDAQ: CASM ) ... today announced that Thomas M. Patton , ... nd Annual Marcum MicroCap Conference on Thursday, May 30, ... York City . The presentation is scheduled ... room and will be available via a live webcast at ...
(Date:5/23/2013)... May 23, 2013 Halozyme Therapeutics, Inc. ... appointment of David A. Ramsay ... most recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and ... working in our commercial group for the last ...
(Date:5/23/2013)... May 23, 2013 EarlySense, the ... that the prize for ,Best Novel Idea, at the ... Emergency Teams International Conference, hosted this year in the ... to a clinical research team studying the impact of ... in Los Angeles . The prize ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4
... Radiation Therapy Services Holdings, Inc. ("Radiation Therapy Services" or the ... the Wells Fargo Securities 2011 Healthcare Conference on Wednesday, June ... being held at the Intercontinental Hotel in Boston, MA. ... be available by visiting the Events section of the Company,s ...
... N.J., June 17, 2011 Affineti Biologics has received ... Capital Group (FVCG) to advance its research in the ... discoveries in oral biology and dental medicine. ... company invested in Affineti because positive results from studies ...
Cached Medicine Technology:Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products 2
(Date:5/23/2013)... ROCHESTER, Minn. -- Mayo Clinic researchers have used next ... more aggressive prostate cancer tumors have similar genetic origins, ... appear online today in the journal Cancer Research ... DNA alterations using next generation sequencing in adjacent Gleason ... genomics with changes in pathology," says ,John Cheville, M.D., ...
(Date:5/23/2013)... 2013 Transvaginal mesh lawsuit ... to move forward in a federal multidistrict litigation underway ... Bernstein Liebhard LLP reports. In an Order issued ... C.R. Bard to seal emails that included supplier information ... confidential, proprietary information about its suppliers. The emails were ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 The vast ... great deal of control over their level of physical ... yet far fewer are actually taking that control. ... Information Council (IFIC) Foundation’s 2013 Food & Health Survey. ... say it’s possible to have “a great deal of ...
(Date:5/23/2013)... On April 29th, 2013, UV Technologies issued ... H7N9 cases and deaths. The headline read, " UV Technologies, ... in Northern Hemisphere as Available Daylight Increases .” In fact, ... , Quoting Kevin McGuire, president of UV Technologies, "The ... in the spring and leaves changing in the fall. The ...
(Date:5/23/2013)... Cheap Concert Tickets announces that Paul McCartney ... stadiums throughout North America. This well known ticket website ... tickets to help McCartney fans see Sir Paul live in ... that she is also offering the customer appreciation code SAVE ... baby boomer, she is also a huge McCartney fan and ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2
... ... more insecure about how they look, often creating depression. Jami Lin presents how not ... body appreciation. , ... (Vocus) August 24, 2009 -- From Hollywood glam to commercials promising ageless beauty, women ...
... ... and forthright look at why Americans are overweight, overwhelmed, and confused, and what ... ... August 25, 2009 -- The question is not whether Americans are getting fatter ...
... of melanosomes--the organelles in pigment-producing cells--may enhance the activity ... new study published online August 24 in the ... examine the role of melanosomes in the sensitivity of ... Hearing, Ph.D., Michael M. Gottesman, M.D., of the Laboratory ...
... , SCOTTSDALE, Ariz., Aug. 24 Matrixx ... will host its 2009 Annual Meeting of Stockholders at 10:00 a.m. ... Scottsdale, Arizona. The purpose of the meeting is to elect three ... two-year or three-year term, or until their successors are elected; to ...
... , , , ... health care, says Legion , , LOUISVILLE, ... expansion of the healthcare systems administered by the Department of Veterans Affairs ... In resolutions adopted by members of its National Executive Committee (NEC), the ...
... those who did it a lot fared worse on tests ... You may think e-mailing, texting, talking on the phone and ... efficient, but new research suggests the opposite is true. , ... is a challenge for the human brain, according to a ...
Cached Medicine News:Health News:Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL 2Health News:Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL 3Health News:Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL 4Health News:The Naked Truth: Overweight, Overwhelmed and Confused 2Health News:Matrixx Initiatives to Webcast 2009 Annual Stockholder Meeting Wednesday, August 26, 2009 2Health News:The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 2Health News:Chronic Media Multi-Tasking Makes It Harder to Focus 2Health News:Chronic Media Multi-Tasking Makes It Harder to Focus 3
... provides a simple, fast and cost-effective method ... samples. This system utilizes guanidine thiocyanate and ... and denature proteins. Purified viral RNA is ... and RNase protection assays. This system is ...
... The Titertek MAP-C2 is designed for ... the instrument is the S60 Stacker that ... removable magazines. The MAP-C2 base model is ... assembly. Auxiliary Digiflex pipetting units may be ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
The IL 682 is the Gold Standard for CO-Oximetry analysis....
Medicine Products: